Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Development of a High-Throughput Dual Stream LC/MS/MS method to screen for inhibitors of Glutamate Carboxypeptidase II (GCPII)
  • +10
  • Nate Hoxie,
  • Yixuan Qiu,
  • Stephen C. Kales,
  • Rick Schneider,
  • Xin Hu,
  • Anu Dalal,
  • Stephanie L. Ford-Scheimer,
  • Robyn Wiseman,
  • Takashi Tsukamoto,
  • Huijun Wei,
  • Barbara S. Slusher,
  • John Janiszewski,
  • Matthew D. Hall
Nate Hoxie
National Center for Advancing Translational Sciences

Corresponding Author:[email protected]

Author Profile
Yixuan Qiu
National Center for Advancing Translational Sciences
Author Profile
Stephen C. Kales
National Center for Advancing Translational Sciences
Author Profile
Rick Schneider
National Center for Advancing Translational Sciences
Author Profile
Xin Hu
National Center for Advancing Translational Sciences
Author Profile
Anu Dalal
National Center for Advancing Translational Sciences
Author Profile
Stephanie L. Ford-Scheimer
National Center for Advancing Translational Sciences
Author Profile
Robyn Wiseman
Johns Hopkins University Department of Pharmacology and Molecular Sciences
Author Profile
Takashi Tsukamoto
Johns Hopkins Medicine Drug Discovery Core
Author Profile
Huijun Wei
Johns Hopkins Medicine Drug Discovery Core
Author Profile
Barbara S. Slusher
Johns Hopkins Medicine Drug Discovery Core
Author Profile
John Janiszewski
National Center for Advancing Translational Sciences
Author Profile
Matthew D. Hall
National Center for Advancing Translational Sciences
Author Profile

Abstract

RATIONALE: Glutamate carboxypeptidase II (GCPII) catalyzes the hydrolysis of N-acetyl-aspartyl-glutamate (NAAG) to yield glutamate (Glu) and N-acetyl-aspartate (NAA). Inhibition of GCPII has been shown to remediate the neurotoxicity of excess glutamate in a variety of cell and animal disease models. A robust high-throughput LC/MS/MS method was needed to quantify GCPII enzymatic activity in a biochemical high-throughput screening assay. METHODS: A dual-stream LC/MS/MS method was developed. Two parallel eluent streams ran identical HILIC gradient methods on BEH-Amide (2x30mm) columns. Each LC Channel was run independently, the cycle time was 2 min per channel. Overall throughput was 1-minute per sample for the dual-channel integrated system. Multiply injected acquisition files were split during data review, batch metadata was automatically paired with raw data during the review process. RESULTS: Two LC sorbents, BEH-Amide and Penta- HILIC, were tested to separate the NAAG cleavage product Glu from isobaric interference and ion suppressants in the bioassay matrix. Early elution of NAAG and NAA on BEH-Amide allowed interfering species to be diverted to waste. The limit of quantification was 0.1 picomoles for Glu. The Z-factor of this assay averaged 0.85. Over 36,000 compounds were screened using this method. CONCLUSIONS: A fast gradient dual-stream LC/MS/MS method for Glu quantification in GCPII biochemical screening assay samples was developed and validated. HILIC separation chemistry offers robust performance and unique selectivity for targeted positive mode quantification of Glu, NAA and NAAG.
13 Mar 2024Submitted to Rapid Communications in Mass Spectrometry
13 Mar 2024Submission Checks Completed
13 Mar 2024Assigned to Editor
13 Mar 2024Review(s) Completed, Editorial Evaluation Pending
14 Mar 2024Reviewer(s) Assigned
25 Apr 20241st Revision Received
27 Apr 2024Review(s) Completed, Editorial Evaluation Pending